AVILEX PHARMA ApS: Financial statements 2016
CVR: 34896828
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
AVILEX PHARMA ApS (CVR 34896828) has filed annual accounts for 2016. In 2016, the company reported a net result of DKK -5,450,675 compared with DKK -7,570,524 the year before. Equity in the 2016 report amounted to DKK -5,729,893. The company had 1 employee in the financial year.
- Profit/Loss
- DKK -5,450,675
- Equity
- DKK -5,729,893
- Total Assets
- DKK 4,780,280
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | - | -5.5 mio. | -5.7 mio. | 1 |
| 2015 | - | - | -7.6 mio. | -279 t. | 3 |
| 2014 | - | - | -1.2 mio. | -4.1 mio. | 0 |
| 2013 | - | - | -2.9 mio. | -2.9 mio. | - |
Official annual report
Find more companies like AVILEX PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of May 20, 2016, Emmanuelle Coutanceau has joined the board of directors of AVILEX PHARMA ApS.
As of May 20, 2016, Raymond George Hill has joined the board of directors of AVILEX PHARMA ApS.
AVILEX PHARMA ApS has published its annual report for 2015. The net result was DKK -7,570,524.
As of May 19, 2016, Emmanuelle Coutanceau has left the board of directors of AVILEX PHARMA ApS.
As of May 19, 2016, Raymond George Hill has left the board of directors of AVILEX PHARMA ApS.
As of January 17, 2016, Kristian Strømgaard is registered as director of AVILEX PHARMA ApS.
As of January 17, 2016, Jonathan Mark Treherne is registered as adm. dir. of AVILEX PHARMA ApS.
As of January 16, 2016, Kristian Strømgaard has stepped down as adm. dir. of AVILEX PHARMA ApS.
About AVILEX PHARMA ApS
AVILEX PHARMA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kristian Strømgaard. The board consists of Raymond George Hill (chair), Camilla Petrycer Hansen, Jonathan Mark Treherne and Kristian Strømgaard. The company's owners include Novo Holdings A/S, MIKAEL SØNDERGÅRD THOMSEN ApS and KRISTIAN STRØMGAARD HOLDING ApS. The company has 3 employees (2018). In 2025, the company reported a net result of DKK -4,530,000 compared with DKK -4,428,000 the year before. Equity in the 2025 report amounted to DKK -10,797,000.